|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-6-28
|
|
pubmed:abstractText |
It has recently been shown that increased body weight is associated with prolactinomas and that weight loss occurs with normalization of prolactin levels. On the other hand, decreased dopaminergic tone in humans is well correlated with obesity. The objective of this study was to correlate changes in prolactin levels with leptin and body mass index (BMI) in patients with prolactinomas treated with the long-acting dopamine agonist bromocriptine (BC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
147
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
77-84
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12088923-Adolescent,
pubmed-meshheading:12088923-Adult,
pubmed-meshheading:12088923-Basal Metabolism,
pubmed-meshheading:12088923-Body Weight,
pubmed-meshheading:12088923-Bromocriptine,
pubmed-meshheading:12088923-Dopamine,
pubmed-meshheading:12088923-Female,
pubmed-meshheading:12088923-Hormone Antagonists,
pubmed-meshheading:12088923-Humans,
pubmed-meshheading:12088923-Hyperprolactinemia,
pubmed-meshheading:12088923-Leptin,
pubmed-meshheading:12088923-Male,
pubmed-meshheading:12088923-Middle Aged,
pubmed-meshheading:12088923-Obesity,
pubmed-meshheading:12088923-Pituitary Neoplasms,
pubmed-meshheading:12088923-Prolactin,
pubmed-meshheading:12088923-Prolactinoma
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine.
|
|
pubmed:affiliation |
Institute of Endocrinology, University Clinical Center, Belgrade, Yugoslavia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
